Nolan E E, Gadow K D
Department of Psychiatry and Behavioral Science, SUNY at Stony Brook 11794-8790, USA.
J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):597-604. doi: 10.1097/00004583-199705000-00009.
To examine behavioral differences between children with attention-deficit hyperactivity disorder (ADHD) and tics and their peers and the extent to which methylphenidate (0.1, 0.3, and 0.5 mg/kg) normalized the behavior of probands and indirectly influenced the behavior of peers (treatment spillover).
Thirty-four prepubertal children with ADHD and chronic tic disorder (who were participating in a double-blind, placebo-controlled methylphenidate evaluation) and their peers were observed for approximately 20 hours in the school setting (classroom seatwork activities, lunchroom, and playground).
Children with ADHD and tics were more inattentive and more disruptive in the classroom and more aggressive in all school settings than their peers. Although treatment with methylphenidate made probands less easily distinguished from their peers (normalization), many children still scored in the deviant range for at least one ADHD behavior when receiving the 0.5-mg/kg dose. There was little evidence that peer behavior improved as a function of the proband's dose of medication.
Although conventional doses of methylphenidate produced dramatic clinical improvement in ADHD-related behavior, complete behavioral normalization is often not attained.
研究患有注意力缺陷多动障碍(ADHD)和抽动症的儿童与其同龄人之间的行为差异,以及哌甲酯(0.1、0.3和0.5mg/kg)在多大程度上使先证者的行为正常化并间接影响同龄人的行为(治疗溢出效应)。
对34名患有ADHD和慢性抽动症的青春期前儿童(他们参与了一项双盲、安慰剂对照的哌甲酯评估)及其同龄人在学校环境(课堂作业活动、餐厅和操场)中进行了约20小时的观察。
患有ADHD和抽动症的儿童在课堂上比同龄人更不专心、更具干扰性,在所有学校环境中也更具攻击性。虽然哌甲酯治疗使先证者与同龄人之间的差异不那么明显(行为正常化),但许多儿童在接受0.5mg/kg剂量时,至少有一种ADHD行为的得分仍处于异常范围。几乎没有证据表明同龄人的行为会随着先证者药物剂量的变化而改善。
虽然常规剂量的哌甲酯在ADHD相关行为方面产生了显著的临床改善,但通常无法实现完全的行为正常化。